<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=30219"><dc:title>The financial toxicity of breast cancer</dc:title><dc:creator>Ratoša,	Ivica	(Avtor)
	</dc:creator><dc:creator>Bavdaž,	Mojca	(Avtor)
	</dc:creator><dc:creator>Došenović Bonča,	Petra	(Avtor)
	</dc:creator><dc:creator>Zobec Logar,	Helena Barbara	(Avtor)
	</dc:creator><dc:creator>Perhavec,	Andraž	(Avtor)
	</dc:creator><dc:creator>Skubic,	Marjeta	(Avtor)
	</dc:creator><dc:creator>Vöröš,	Katja	(Avtor)
	</dc:creator><dc:creator>Mihor,	Ana	(Avtor)
	</dc:creator><dc:creator>Zadnik,	Vesna	(Avtor)
	</dc:creator><dc:creator>Redek,	Tjaša	(Avtor)
	</dc:creator><dc:subject>health services</dc:subject><dc:subject>financing</dc:subject><dc:subject>literature review</dc:subject><dc:description>Background - Breast cancer is one of the most common cancers, increasingly prevalent also among working-age populations. Regardless of age, breast cancer has significant direct and indirect costs on the individuals, families and society. The aim of the research was to provide a comprehensive bibliometric analysis of the financial toxicity of breast cancer, to identify research voids and future research challenges. Materials and methods - The systematic mapping of literature relied on a multi-method approach, combining bibliometric methods with a standard review/discussion of most important contributions. The analysis employed Bibliometrics in R and VosViewer. Results - The results highlighted the key authors, journals and research topics in the investigation of the financial toxic- ity of cancer and stressed the concentration of work around several authors and journals. Conclusions -The results also revealed a lack of a comprehensive approach in the study of financial toxicity, as the literature often focuses on one or few selected aspects of financial toxicity. In addition, geographic coverage is un- even and differences in the healthcare systems represent a challenge to straightforward comparisons.</dc:description><dc:publisher>Association of Radiology and Oncology</dc:publisher><dc:date>2025</dc:date><dc:date>2026-06-17 14:42:11</dc:date><dc:type>Neznano</dc:type><dc:identifier>30219</dc:identifier><dc:source>Ljubljana</dc:source><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
